MoneyWorks4Me

Nectar Lifesciences completes sale of API and formulations business

12 Nov 2025 Evaluate

Nectar Lifesciences has completed the slump sale of its active pharmaceutical ingredients (API) and formulations business (Business) to Ceph Lifesciences in accordance with the terms of the business transfer agreement (BTA). The company has also completed the asset sale to Ceph Lifesciences. The transfer is completed with effect from November 10, 2025. 

Incorporated in 1995, Nectar Lifesciences is a leading global manufacturer of cephalosporin antibiotics medicines.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..